$NEPH·4

NEPHROS INC · Aug 26, 5:35 PM ET

NEPHROS INC 4

4 · NEPHROS INC · Filed Aug 26, 2016

Insider Transaction Report

Form 4
Period: 2016-08-24
Transactions
  • Award

    Common Stock

    2016-08-24+113,636151,605 total
  • Award

    Stock Option (Right to Buy)

    2016-08-24+33,88033,880 total
    Exercise: $0.40Exp: 2026-08-24Common Stock (33,880 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    31,160
  • Stock Option (Right to Buy)

    Exercise: $0.79Exp: 2025-05-07Common Stock (56,981 underlying)
    56,981
  • Warrants (right to buy)

    (indirect: By Spouse)
    Exercise: $0.85From: 2015-05-12Exp: 2020-05-18Common Stock (15,580 underlying)
    15,580
Footnotes (4)
  • [F1]On August 24, 2016, the Company granted 73,864 shares of restricted stock of the Company (the "Restricted Stock") in lieu of $40,000 in cash fees payable to Mr. Persen in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]Due to an administrative error, the Reporting Person's Form 4 filed in September 2015 reported the dollar value of his grant instead of the number of shares actually granted (37,969) and this report accurately reflects the Reporting Person's total direct ownership.
  • [F3]The options vest as to 18,994 shares on each of 5/7/15 and 5/7/16 and as to 18,993 shares on 5/7/17.
  • [F4]On August 24, 2016, the Company granted an option to purchase 33,880 shares of common stock of the Company (the "Option") in respect of the service by Mr. Persen as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. This option vests as to 11,294 shares on 8/24/16 and as to 11,293 shares on each of 8/24/17 and 8/24/18.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT